AMZN
210.15
+2.4%↑
TSLA
380.77
+3.53%↑
HD
330.77
+3.02%↑
TM
210.24
+2.62%↑
MCD
308.25
-0.38%↓
AMZN
210.15
+2.4%↑
TSLA
380.77
+3.53%↑
HD
330.77
+3.02%↑
TM
210.24
+2.62%↑
MCD
308.25
-0.38%↓
AMZN
210.15
+2.4%↑
TSLA
380.77
+3.53%↑
HD
330.77
+3.02%↑
TM
210.24
+2.62%↑
MCD
308.25
-0.38%↓
AMZN
210.15
+2.4%↑
TSLA
380.77
+3.53%↑
HD
330.77
+3.02%↑
TM
210.24
+2.62%↑
MCD
308.25
-0.38%↓
AMZN
210.15
+2.4%↑
TSLA
380.77
+3.53%↑
HD
330.77
+3.02%↑
TM
210.24
+2.62%↑
MCD
308.25
-0.38%↓
24h
Curent
Minim
7.21
Maxim
7.83
Venit | 6.2M -6.4M |
|---|---|
Vânzări | -49M 663M |
EPS | -0.049 |
Randament dividend | 1.95 |
Marjă de profit | -0.963 |
Angajați | 18,150 |
EBITDA | -808K 48M |
Recomandări | Vânzare |
|---|---|
Prognoză pe 12 luni | +12.83% upside |
Randament dividend Medie Sector | 1.95% 3.17% |
|---|---|
Următoarele câștiguri | 5 mai 2026 |
Capitalizare de piață | -80M 705M |
|---|---|
Deschiderea anterioară | 0.83 |
Închiderea anterioară | 7.74 |
By Acuity
26%
74%
58 / 338 Clasament în Consumer cyclical
Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.
23 mar. 2026, 23:47 UTC
Gilead Sciences to Buy Ouro Medicines, Collaborate With Galapagos on Purchased Assets -- Update
DJ
Citește
23 mar. 2026, 22:55 UTC
Gilead Sciences to Buy Ouro Medicines for Up to $2.18 Billion
DJ
Citește
23 mar. 2026, 21:51 UTC
Italy's Postal Service Makes $12.50 Billion Bid for Telecom Italia -- 3rd Update
DJ
Citește
23 mar. 2026, 23:59 UTC
Global Equities Roundup: Market Talk
DJ
Citește
23 mar. 2026, 23:59 UTC
Woodside, Santos Earnings Power Up on Surging LNG Prices -- Market Talk
DJ
Citește
23 mar. 2026, 23:50 UTC
Nikkei May Rise on Hopes for U.S. Talks With Iran -- Market Talk
DJ
Citește
23 mar. 2026, 23:37 UTC
Gold Rises, Boosted by Fall in Dollar, U.S. Treasury Yields -- Market Talk
DJ
Citește
23 mar. 2026, 22:42 UTC
Global Equities Roundup: Market Talk
DJ
Citește
23 mar. 2026, 22:42 UTC
Bell Potter Names Miners Less Exposed to Fuel Price, Supply Risks -- Market Talk
DJ
Citește
23 mar. 2026, 22:40 UTC
Gilead Sciences to Buy Ouro Medicines for Up to $2.18B
DJ
Citește
23 mar. 2026, 22:23 UTC
Apollo Debt Solutions Shrugs Off Private-Credit Fears -- Market Talk
DJ
Citește
23 mar. 2026, 22:22 UTC
Gilead Sciences: OM336 Is for Treatment of Autoantibodies Driven Immune-Mediated Disease
DJ
Citește
23 mar. 2026, 22:21 UTC
Gilead Sciences: Company Would Pay Galapagos Royalties of 20%-23% of Net OM336 Sales
DJ
Citește
23 mar. 2026, 22:21 UTC
Gilead Sciences: Company Would Retain Sole Worldwide Commercialization Rights of OM336 Outside of Greater China
DJ
Citește
23 mar. 2026, 22:20 UTC
Gilead Sciences: Company, Galapagos Would Collaborate on Development of OM336 >GILD
DJ
Citește
23 mar. 2026, 22:20 UTC
Gilead Sciences: Galapagos Would Absorb Substantially All of Ouro's Operating Assets, Retain Its Employees >GILD
DJ
Citește
23 mar. 2026, 22:19 UTC
Gilead Sciences: Galapagos Would Pay 50% of Upfront Consideration and 50% of Any Contingent Milestone Payments Payable to Ouro Shareholders
DJ
Citește
23 mar. 2026, 22:19 UTC
Gilead Sciences: Currently in Advanced Discussions With Galapagos With Respect to Potential Research-and-Development Collaboration on Acquired Ouro Assets
DJ
Citește
23 mar. 2026, 22:18 UTC
Gilead Sciences to Buy Ouro Medicines for About $1.68B Upfront, Up to $500M in Contingent Milestone Payments >GILD
DJ
Citește
23 mar. 2026, 22:15 UTC
Gilead Sciences To Acquire Ouro Medicines To Advance First In Class T Cell Engager Program For Autoimmune Diseases >GILD
DJ
Citește
23 mar. 2026, 22:08 UTC
Ebos Needs to Reset Its Gearing Targets -- Market Talk
DJ
Citește
23 mar. 2026, 21:42 UTC
Global Forex and Fixed Income Roundup: Market Talk
DJ
Citește
23 mar. 2026, 21:42 UTC
RBNZ's Breman Strikes Reassuring Tone On Rates -- Market Talk
DJ
Citește
23 mar. 2026, 21:32 UTC
WuXi XDC Cayman: Results Aided by Strong Growth in Contract Research, Development and Manufacturing Organisation Business>2268.HK
DJ
Citește
23 mar. 2026, 21:32 UTC
WuXi XDC Cayman 2025 Net CNY1.56B Vs. Net CNY917.16M >2268.HK
DJ
Citește
23 mar. 2026, 21:32 UTC
WuXi XDC Cayman 2025 Rev CNY5.94B Vs. CNY4.05B >2268.HK
DJ
Citește
23 mar. 2026, 21:10 UTC
Oil Is Back Under $100. Trump Says Iran Has Agreed to No Nuclear Weapons. -- Barrons.com
DJ
Citește
23 mar. 2026, 20:50 UTC
Tech, Media & Telecom Roundup: Market Talk
DJ
Citește
23 mar. 2026, 20:50 UTC
Health Care Roundup: Market Talk
DJ
Citește
23 mar. 2026, 20:50 UTC
Basic Materials Roundup: Market Talk
DJ
Citește
Modificare preț
By TipRanks
Prognoză pe 12 luni
Medie 8.18 USD 12.83%
Maxim 10 USD
Minim 6 USD
În baza a 7 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruVestis Corp - Dist în ultimele 3 luni.
By TipRanks
Vânzare
7 ratings
1
Cumpărare
3
Păstrare
3
Vânzare
Ținând cont de 7 analiști care au acordat evaluări ale acțiunilor Vestis Corp - Dist în ultimele 3 luni.
By Acuity
Sentimentul știrilor
Evidențe de creștere
Volatilitate
Sub medie
Volumul știrilor (RCV)
Sub medie
Cheltuieli de vânzare și administrare
Cheltuieli de exploatare
Profit pre-impozitare
Vânzări
Costul vânzărilor
Profit brut din vânzări
Cheltuieli cu dobânzile pe datorie
EBITDA
Profit operațional
$